HairEvidence check
4 Findings About Cetirizine Scalp Solutions for Hair Loss
Women's trials, a newer mixed-sex study and a small male pilot give different reasons to question regrowth claims.
The library
Every article, in one place.
Breath & MouthComparison
Cevimeline for Sjögren's: Dry-Mouth Relief and Saliva Flow
Three placebo-controlled studies help distinguish reported comfort from measured saliva production, with a higher-dose comparison that adds a caution.
Bladder & Pelvic FloorEvidence check
Cranberry for Bladder Urgency: The Analyses Behind Two Trials
A 24-week trial and an October 2026 pilot give qualified findings.
PeriodsEvidence check
4 Findings About Curcumin Capsules for Period Cramps
Three placebo-controlled trials reported different pain results. Formulations, rescue painkillers and inconsistent participant counts affect how much confidence to place in them.
Daridorexant at Midlife: What the Menopause-Age Subgroup Shows
The subgroup findings, current trial status and prescribing precautions.
SkinQ&A
Delgocitinib for Hand Eczema: Questions Before a Prescription
Who Anzupgo is for, what its trials measured and what to review before starting.
Intimate HealthComparison
Dequalinium for BV: Early Clinical Cure and Four-Week Symptoms
The 2024 trial and the larger 2026 DEVA abstract measured different outcomes at different times.
PeriodsEvidence check
Dill for Period Pain: Seed Powder, Drops and Drug Comparisons
Three small trials used different preparations. Similar pain scores do not establish interchangeable treatments.
Menopause & HormonesEvidence check
4 Findings About Elinzanetant During Breast Cancer Endocrine Therapy
OASIS-4 found fewer hot flashes during endocrine therapy. Its selected population, 12-week placebo comparison and reported adverse events define what that result can support.
Bloating & DigestionExplainer
Elobixibat for Constipation: More Bowel Movements, Less Certain Bloating Relief
A two-week Indian trial found a stool-frequency benefit. Its bloating result shows why follow-up needs more than a count.
Menopause & HormonesEvidence check
Escitalopram for Hot Flashes: Four Trial and Prescribing Findings
An eight-week trial found fewer diary-recorded flashes. Smaller recorder studies and current prescribing warnings add context.
Menopause & HormonesEvidence check
Estetrol for Menopause: Four Fylrevy Evidence Checks
The EU indication, weekly hot-flash results, dose terminology and uterine-lining precautions.
